Annual Working Capital
$44.84 M
-$109.53 M-70.95%
December 31, 2023
Summary
- As of February 7, 2025, ESPR annual working capital is $44.84 million, with the most recent change of -$109.53 million (-70.95%) on December 31, 2023.
- During the last 3 years, ESPR annual working capital has fallen by -$206.99 million (-82.19%).
- ESPR annual working capital is now -82.46% below its all-time high of $255.62 million, reached on December 31, 2021.
Performance
ESPR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$141.68 M
-$28.09 M-16.54%
September 30, 2024
Summary
- As of February 7, 2025, ESPR quarterly working capital is $141.68 million, with the most recent change of -$28.09 million (-16.54%) on September 30, 2024.
- Over the past year, ESPR quarterly working capital has dropped by -$28.09 million (-16.54%).
- ESPR quarterly working capital is now -48.08% below its all-time high of $272.89 million, reached on March 31, 2015.
Performance
ESPR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ESPR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.0% | -16.5% |
| 3 y3 years | -82.2% | -16.5% |
| 5 y5 years | -42.7% | -27.7% |
ESPR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.5% | at low | -44.6% | +216.0% |
| 5 y | 5-year | -82.5% | at low | -44.6% | +216.0% |
| alltime | all time | -82.5% | +546.9% | -48.1% | +1511.9% |
Esperion Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $141.68 M(-16.5%) |
| Jun 2024 | - | $169.77 M(-15.6%) |
| Mar 2024 | - | $201.09 M(+348.5%) |
| Dec 2023 | $44.84 M(-71.0%) | $44.84 M(-44.3%) |
| Sep 2023 | - | $80.52 M(-35.6%) |
| Jun 2023 | - | $124.95 M(-19.4%) |
| Mar 2023 | - | $155.12 M(+0.5%) |
| Dec 2022 | $154.38 M(-39.6%) | $154.38 M(-14.0%) |
| Sep 2022 | - | $179.44 M(+5.4%) |
| Jun 2022 | - | $170.20 M(-19.6%) |
| Mar 2022 | - | $211.73 M(-17.2%) |
| Dec 2021 | $255.62 M(+1.5%) | $255.62 M(+177.3%) |
| Sep 2021 | - | $92.18 M(-52.1%) |
| Jun 2021 | - | $192.53 M(+10.2%) |
| Mar 2021 | - | $174.68 M(-30.6%) |
| Dec 2020 | $251.83 M(+72.9%) | $251.83 M(+50.9%) |
| Sep 2020 | - | $166.86 M(-29.7%) |
| Jun 2020 | - | $237.49 M(+139.5%) |
| Mar 2020 | - | $99.18 M(-31.9%) |
| Dec 2019 | $145.63 M(+86.0%) | $145.63 M(-25.7%) |
| Sep 2019 | - | $195.94 M(-22.5%) |
| Jun 2019 | - | $252.81 M(+44.3%) |
| Mar 2019 | - | $175.20 M(+123.8%) |
| Dec 2018 | $78.30 M | $78.30 M(-37.8%) |
| Sep 2018 | - | $125.92 M(-18.2%) |
| Jun 2018 | - | $153.92 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $171.36 M(+0.3%) |
| Dec 2017 | $170.78 M(-13.7%) | $170.78 M(-0.6%) |
| Sep 2017 | - | $171.83 M(+22.8%) |
| Jun 2017 | - | $139.95 M(-15.9%) |
| Mar 2017 | - | $166.41 M(-16.0%) |
| Dec 2016 | $197.99 M(-5.2%) | $197.99 M(-3.6%) |
| Sep 2016 | - | $205.31 M(+1.9%) |
| Jun 2016 | - | $201.45 M(+5.4%) |
| Mar 2016 | - | $191.06 M(-8.5%) |
| Dec 2015 | $208.77 M(+106.3%) | $208.77 M(-1.5%) |
| Sep 2015 | - | $212.02 M(-3.0%) |
| Jun 2015 | - | $218.68 M(-19.9%) |
| Mar 2015 | - | $272.89 M(+169.6%) |
| Dec 2014 | $101.21 M(+79.4%) | $101.21 M(+106.8%) |
| Sep 2014 | - | $48.95 M(-12.4%) |
| Jun 2014 | - | $55.86 M(+1.4%) |
| Mar 2014 | - | $55.09 M(-2.4%) |
| Dec 2013 | $56.42 M(-662.2%) | $56.42 M(-19.0%) |
| Sep 2013 | - | $69.62 M(+446.3%) |
| Jun 2013 | - | $12.74 M(-35.0%) |
| Mar 2013 | - | $19.60 M(-295.3%) |
| Dec 2012 | -$10.03 M(-2012.1%) | -$10.03 M |
| Dec 2011 | $524.80 K(-98.7%) | - |
| Dec 2002 | $40.33 M(-37.9%) | - |
| Dec 2001 | $64.93 M(+1.2%) | - |
| Dec 2000 | $64.18 M(+1942.0%) | - |
| Dec 1999 | $3.14 M | - |
FAQ
- What is Esperion Therapeutics annual working capital?
- What is the all time high annual working capital for Esperion Therapeutics?
- What is Esperion Therapeutics annual working capital year-on-year change?
- What is Esperion Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly working capital year-on-year change?
What is Esperion Therapeutics annual working capital?
The current annual working capital of ESPR is $44.84 M
What is the all time high annual working capital for Esperion Therapeutics?
Esperion Therapeutics all-time high annual working capital is $255.62 M
What is Esperion Therapeutics annual working capital year-on-year change?
Over the past year, ESPR annual working capital has changed by -$109.53 M (-70.95%)
What is Esperion Therapeutics quarterly working capital?
The current quarterly working capital of ESPR is $141.68 M
What is the all time high quarterly working capital for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly working capital is $272.89 M
What is Esperion Therapeutics quarterly working capital year-on-year change?
Over the past year, ESPR quarterly working capital has changed by -$28.09 M (-16.54%)